![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0108.png)
107
Diretrizes AMB
Am Acad Dermatol. 2008 Jan;58(1):106-15. Epub 2007 Oct 23. PubMed
PMID: 17936411.
23. Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi
CL, Langley RG, Kimel M, Okun M. Impact of adalimumab treatment on
patient-reported outcomes: results from a Phase III clinical trial in
patients with moderate to severe plaque psoriasis. J Dermatolog Treat.
2007;18(6):341-50. PubMed PMID: 18058494.
24. Asahina A, Nakagawa H, Etoh T, Ohtsuki M; Adalimumab M04-688
Study Group. Adalimumab in Japanese patients with moderate to severe